Lepromatous Leprosy with Lucio’s Phenomenon Successfully Treated with Sungai Buloh Augmented Multidrug Treatment in Combination with Systemic Corticosteroids
Malaysian Journal of Dermatology · 2025-01 · 53 (1) · 37-38
DOI: 10.4103/mjd.mjd_10_24 ↗Kurz gefasst
Fachartikel in der Zeitschrift Malaysian Journal of Dermatology, online erschienen am 05.07.2025. Verfasst von Lalitha Kanasen und 4 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 4 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-SA 4.0).
Abstract (Originalsprache)
Lucio’s phenomenon is an immunologically mediated inflammatory state amongst patients with Mycobacterium leprae infection, occurring spontaneously or after initiation of therapy. This case report shows the efficacy of Sungai Buloh Augmented multidrug treatment with addition of corticosteroids in treating a relapsed lepromatous leprosy with Lucio’s phenomenon.
Zitieren
APA
Kanasen, L., Kuppusamy, M., Baharom, Z. F., Ghazali, R., & Diana, T. N. (2025). Lepromatous Leprosy with Lucio’s Phenomenon Successfully Treated with Sungai Buloh Augmented Multidrug Treatment in Combination with Systemic Corticosteroids. Malaysian Journal of Dermatology, 53(1), 37-38. https://doi.org/10.4103/mjd.mjd_10_24
Vancouver
Kanasen L, Kuppusamy M, Baharom ZF, Ghazali R, Diana TN. Lepromatous Leprosy with Lucio’s Phenomenon Successfully Treated with Sungai Buloh Augmented Multidrug Treatment in Combination with Systemic Corticosteroids. Malaysian Journal of Dermatology. 2025;53(1):37-38. doi:10.4103/mjd.mjd_10_24
BibTeX
@article{Kanasen2025,
author = {Kanasen, Lalitha and Kuppusamy, Meera and Baharom, Zuliatul Faizah and Ghazali, Razmin and Diana, Tengku Nor},
title = {Lepromatous Leprosy with Lucio’s Phenomenon Successfully Treated with Sungai Buloh Augmented Multidrug Treatment in Combination with Systemic Corticosteroids},
journal = {Malaysian Journal of Dermatology},
year = {2025},
volume = {53},
number = {1},
pages = {37--38},
doi = {10.4103/mjd.mjd_10_24}
}
EUVIMED